A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01)
Patent
CA 2737376
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
Cette invention concerne des combinaisons thérapeutiques comprenant (a) le composé (1), ou un sel pharmaceutiquement acceptable de celui-ci, tel que ci-décrit, (b) un interféron alpha et (c) de la ribavirine. Le composé (1) est un inhibiteur sélectif et puissant de la sérine protéase NS3 du VHC. La présente invention concerne également des procédés d'utilisation desdites combinaisons thérapeutiques pour traiter une infection par le VHC ou soulager un ou plusieurs de ses symptômes chez un patient.
Huang David
Steinmann Gerhard Gustav
Stern Jerry O.
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Combination of hcv ns3 protease inhibitor with interferon... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of hcv ns3 protease inhibitor with interferon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of hcv ns3 protease inhibitor with interferon... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1360305